Cargando…

Glucocorticoid treatment of suspected organizing pneumonia after H7N9 infection: A case report

RATIONALE: H7N9 infection causes acute respiratory distress syndrome with high mortality. The use of glucocorticoids in the acute phase lessened inflammatory responses. Some case reports suggested that secondary organizing pneumonia (SOP) could occur at the recovery stage of the influenza virus infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Huijiao, Li, Jianwei, Chen, Miaolian, Su, Jiahao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716695/
https://www.ncbi.nlm.nih.gov/pubmed/31441857
http://dx.doi.org/10.1097/MD.0000000000016839
_version_ 1783447421257252864
author Liu, Huijiao
Li, Jianwei
Chen, Miaolian
Su, Jiahao
author_facet Liu, Huijiao
Li, Jianwei
Chen, Miaolian
Su, Jiahao
author_sort Liu, Huijiao
collection PubMed
description RATIONALE: H7N9 infection causes acute respiratory distress syndrome with high mortality. The use of glucocorticoids in the acute phase lessened inflammatory responses. Some case reports suggested that secondary organizing pneumonia (SOP) could occur at the recovery stage of the influenza virus infection, and the treatment with glucocorticoid was effective. However, the reports of organizing pneumonia after H7N9 infection are lacking. This study reported a patient with H7N9 virus infection who presented a suspected SOP during the recovery stage. PATIENT CONCERN: A 68-year-old woman who was diagnosed with H7N9 viral pneumonia. After standard antiviral treatment, venous-venous extracorporeal membranous oxygenation (VV-ECMO) and other supportive treatment, the antigen in the alveolar lavage fluid turned negative, and the shadow in the lung was partially absorbed. However, the imaging manifestations were deteriorated at 3 weeks after disease onset, presented as exudation and consolidation shadow distributed under the pleura and along the bronchial vascular bundles. The oxygenation could not be improved. Repeated sputum, alveolar lavage fluid, and blood pathogen examinations showed negative results. Broad-spectrum anti-infective treatment was ineffective. However, the autoantibodies (ANA, anti-SSA/Ro60, anti-SSA/Ro52) were detected. DIAGNOSIS: SOP was considered. INTERVENTIONS: Glucocorticoid treatment begun at week 4 from the disease onset. The regimen was methylprednisolone at an initial dose of 40 mg twice a day for 1 week, tapering within 70 days until total withdrawal. OUTCOMES: The oxygenation was rapidly improved after initiation of methylprednisolone. The shadow in the lung gradually resolved, and the patient was discharged after improvement of the disease condition. The clinical disease course, imaging findings, and treatment effects in the previous cases of SOP after influenza virus infection were similar to those in this case, suggesting the occurrence of SOP after H7N9 virus infection. LESSONS: Organizing pneumonia might occur during the recovery stage of influenza virus infection. When the clinical symptoms do not improve and the shadow in the lung shows no obvious absorption after elimination of the H7N9 influenza virus, or the clinical symptoms are aggravated again after improvement, the probability of transforming into the organizing pneumonia should be taken into consideration.
format Online
Article
Text
id pubmed-6716695
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-67166952019-10-01 Glucocorticoid treatment of suspected organizing pneumonia after H7N9 infection: A case report Liu, Huijiao Li, Jianwei Chen, Miaolian Su, Jiahao Medicine (Baltimore) 4900 RATIONALE: H7N9 infection causes acute respiratory distress syndrome with high mortality. The use of glucocorticoids in the acute phase lessened inflammatory responses. Some case reports suggested that secondary organizing pneumonia (SOP) could occur at the recovery stage of the influenza virus infection, and the treatment with glucocorticoid was effective. However, the reports of organizing pneumonia after H7N9 infection are lacking. This study reported a patient with H7N9 virus infection who presented a suspected SOP during the recovery stage. PATIENT CONCERN: A 68-year-old woman who was diagnosed with H7N9 viral pneumonia. After standard antiviral treatment, venous-venous extracorporeal membranous oxygenation (VV-ECMO) and other supportive treatment, the antigen in the alveolar lavage fluid turned negative, and the shadow in the lung was partially absorbed. However, the imaging manifestations were deteriorated at 3 weeks after disease onset, presented as exudation and consolidation shadow distributed under the pleura and along the bronchial vascular bundles. The oxygenation could not be improved. Repeated sputum, alveolar lavage fluid, and blood pathogen examinations showed negative results. Broad-spectrum anti-infective treatment was ineffective. However, the autoantibodies (ANA, anti-SSA/Ro60, anti-SSA/Ro52) were detected. DIAGNOSIS: SOP was considered. INTERVENTIONS: Glucocorticoid treatment begun at week 4 from the disease onset. The regimen was methylprednisolone at an initial dose of 40 mg twice a day for 1 week, tapering within 70 days until total withdrawal. OUTCOMES: The oxygenation was rapidly improved after initiation of methylprednisolone. The shadow in the lung gradually resolved, and the patient was discharged after improvement of the disease condition. The clinical disease course, imaging findings, and treatment effects in the previous cases of SOP after influenza virus infection were similar to those in this case, suggesting the occurrence of SOP after H7N9 virus infection. LESSONS: Organizing pneumonia might occur during the recovery stage of influenza virus infection. When the clinical symptoms do not improve and the shadow in the lung shows no obvious absorption after elimination of the H7N9 influenza virus, or the clinical symptoms are aggravated again after improvement, the probability of transforming into the organizing pneumonia should be taken into consideration. Wolters Kluwer Health 2019-08-23 /pmc/articles/PMC6716695/ /pubmed/31441857 http://dx.doi.org/10.1097/MD.0000000000016839 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle 4900
Liu, Huijiao
Li, Jianwei
Chen, Miaolian
Su, Jiahao
Glucocorticoid treatment of suspected organizing pneumonia after H7N9 infection: A case report
title Glucocorticoid treatment of suspected organizing pneumonia after H7N9 infection: A case report
title_full Glucocorticoid treatment of suspected organizing pneumonia after H7N9 infection: A case report
title_fullStr Glucocorticoid treatment of suspected organizing pneumonia after H7N9 infection: A case report
title_full_unstemmed Glucocorticoid treatment of suspected organizing pneumonia after H7N9 infection: A case report
title_short Glucocorticoid treatment of suspected organizing pneumonia after H7N9 infection: A case report
title_sort glucocorticoid treatment of suspected organizing pneumonia after h7n9 infection: a case report
topic 4900
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716695/
https://www.ncbi.nlm.nih.gov/pubmed/31441857
http://dx.doi.org/10.1097/MD.0000000000016839
work_keys_str_mv AT liuhuijiao glucocorticoidtreatmentofsuspectedorganizingpneumoniaafterh7n9infectionacasereport
AT lijianwei glucocorticoidtreatmentofsuspectedorganizingpneumoniaafterh7n9infectionacasereport
AT chenmiaolian glucocorticoidtreatmentofsuspectedorganizingpneumoniaafterh7n9infectionacasereport
AT sujiahao glucocorticoidtreatmentofsuspectedorganizingpneumoniaafterh7n9infectionacasereport